Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells

Proceedings of the National Academy of Sciences of the United States of America
Mecheal KanovskyMatthew R Pincus

Abstract

We have synthesized three peptides from the mdm-2 binding domain of human p53, residues 12-26 (PPLSQETFSDLWKLL), residues 12-20, and 17-26. To enable transport of the peptides across the cell membrane and at the same time to maximize the active mdm-2 binding alpha-helical conformation for these peptides, each was attached at its carboxyl terminus to the penetratin sequence, KKWKMRRNQFWVKVQRG, that contains many positively charged residues that stabilize an alpha-helix when present on its carboxyl terminal end. All three peptides were cytotoxic to human cancer cells in culture, whereas a control, unrelated peptide attached to the same penetratin sequence had no effect on these cell lines. The same three cytotoxic peptides had no effect on the growth of normal cells, including human cord blood-derived stem cells. These peptides were as effective in causing cell death in p53-null cancer cells as in those having mutant or normal p53. Peptide-induced cell death is not accompanied by expression of apoptosis-associated proteins such as Bax and waf(p21). Based on these findings, we conclude that the antiproliferative effects of these p53-derived peptides are not completely dependent on p53 activity and may prove useful as general antic...Continue Reading

References

Oct 24, 1995·Proceedings of the National Academy of Sciences of the United States of America·P RubinsteinC E Stevens
Feb 1, 1995·Current Opinion in Genetics & Development·R Haffner, M Oren
Nov 8, 1996·Science·S C ClemensW L Prell
May 15, 1997·Nature·Y HauptM Oren
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·B F Müller-TiemannJ J Elting
Aug 8, 1998·Trends in Cell Biology·D DerossiA Prochiantz
Sep 2, 1998·Proceedings of the National Academy of Sciences of the United States of America·S Y FuchsZ Ronai
Feb 3, 1999·Bioinformatics·K KarplusR Hughey
Mar 5, 1999·Cellular and Molecular Life Sciences : CMLS·D A FreedmanA J Levine
Apr 13, 2000·International Journal of Cancer. Journal International Du Cancer·J KleeffM Korc
Mar 17, 2001·Nature Reviews. Molecular Cell Biology·A Yang, F McKeon

❮ Previous
Next ❯

Citations

Feb 26, 2010·Cancer Chemotherapy and Pharmacology·Kelley A SookrajMatthew R Pincus
Sep 27, 2002·Current Opinion in Pharmacology·Mark A Lindsay
Jan 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Ehsan Sarafraz-YazdiMatthew R Pincus
Jul 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Min LiuWuyuan Lu
Nov 29, 2007·Current Opinion in Oncology·Wenge Wang, Wafik S El-Deiry
Dec 10, 2009·World Journal of Gastroenterology : WJG·Li-Ping SongGuang-Xiao Yang
Oct 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Tohru YamadaAnanda M Chakrabarty
Jun 3, 2014·Microbial Cell Factories·Vida RodríguezBarbara A Andrews
Oct 16, 2004·Molecular and Cellular Neurosciences·Gunnar P H Dietz, Mathias Bähr
Jun 15, 2005·Expert Opinion on Biological Therapy·Corina BorghoutsBernd Groner
Jul 30, 2009·Expert Opinion on Drug Delivery·Gene L Bidwell, Drazen Raucher
Aug 19, 2010·Histopathology·Magdalena ZietarskaAnne-Marie Mes-Masson
Sep 11, 2004·Protein Expression and Purification·Zhihong LiuStephen W Fesik
Jul 29, 2004·DNA Repair·David W Meek
Oct 18, 2005·Regulatory Peptides·Richard N Re, Julia L Cook
Jul 16, 2008·Seminars in Cell & Developmental Biology·Bernd GronerCorina Borghouts
Jan 15, 2015·Applied Biochemistry and Biotechnology·Vida RodríguezBarbara A Andrews
Feb 4, 2003·Nature Reviews. Cancer·Patrick Chène
Mar 3, 2006·Chembiochem : a European Journal of Chemical Biology·Rudi FasanJohn A Robinson
Aug 7, 2018·PloS One·Ewa Pasquereau-KotulaJean-Luc Poyet
May 12, 2006·International Journal of Cancer. Journal International Du Cancer·Josef MichlMatthew R Pincus
Sep 3, 2005·Journal of Peptide Science : an Official Publication of the European Peptide Society·Corina BorghoutsBernd Groner
Dec 13, 2005·The Journal of Biological Chemistry·Ambrus TothPeter Erhardt
Jun 7, 2006·The Journal of Biological Chemistry·Ying WangDalong Ma
May 31, 2003·Oncogene·Marcus Achison, Ted R Hupp
Mar 17, 2004·Oncogene·Yili YangAllan M Weissman
Mar 23, 2017·Journal of Biomedical Science·Susan MarqusTerrence J Piva
Jan 13, 2005·International Journal of Cancer. Journal International Du Cancer·Yin LiRobert L Fine
Mar 10, 2009·Chembiochem : a European Journal of Chemical Biology·Martin HintersteinerManfred Auer
Oct 18, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Emily A BassettWafik S El-Deiry
Jul 14, 2016·Cancer Research·Léonard Jagot-LacoussiereJean-Luc Poyet
May 3, 2007·The Journal of Physical Chemistry. a·Carolina Barrientos-SalcedoCatalina Soriano-Correa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis